Nate Raymond

Reuters

@nateraymond

  • Currently a legal affairs correspondent for Reuters covering Boston courts, health, and pharmaceutical cases.
  • Graduated from the University of Alaska Fairbanks with a degree in Journalism
  • Previously served as a reporter for The Am Law Litigation Daily.
New York doctor pleads guilty to taking kickbacks from Insys

Feb 14

A New York doctor on Thursday pleaded guilty to accepting kickbacks from Insys Therapeutics Inc in exchange for prescribing a potent fentanyl spray called Subsys that is intended only for treating severe pain in cancer patients.'

Read this Story

U.S. judge sees problems in Harvard Asian-American bias case

Feb 14

A federal judge weighing whether Harvard University discriminates against Asian-American applicants said on Wednesday both the Ivy League school and a non-profit suing it faced potential problems in proving their positions.

Read this Story

Judge blocks expert testimony about safety of USPlabs supplement

Feb 11

Dietary supplement maker USPlabs LLC and several executives have won a ruling preventing prosecutors from calling at trial expert witnesses who would testify that one of its products linked to a 2013 outbreak of liver injuries was toxic and unsafe for humans.

Read this Story

Trump administration fights House bid to defend Obamacare in court

Feb 9

The Trump administration urged a federal appeals court on Friday to block the Democratic-led U.S. House of Representatives from intervening in a lawsuit challenging the constitutionality of the Affordable Care Act.'

Read this Story

Ex-prosecutors argue against colleague's disqualification in opioid MDL

Feb 9

A group of 22 former U.S. attorneys are warning that a ruling disqualifying a colleague from representing a drugmaker in litigation over the opioid epidemic could make it "impossible" for former government lawyers to work in private practice.'

Read this Story

GSK loses bid to escape Zofran birth defect lawsuits

Feb 6

A federal judge has rejected GlaxoSmithKline PLC's bid to dismiss hundreds of lawsuits by women who claim the drugmaker failed to warn them about the risks of birth defects associated with using Zofran, an antinausea medication, during pregnancy.'

Read this Story

U.S. sues to block Philadelphia safe drug-injection site

Feb 6

The U.S. Justice Department on Wednesday said it had filed a lawsuit seeking to stop a nonprofit in Philadelphia from opening what could become the nation's first supervised drug-injection site in an effort aimed at addressing opioid abuse.

Read this Story

Massachusetts top court upholds teen texting suicide verdict

Feb 6

Massachusetts' top court on Wednesday upheld a woman's conviction for manslaughter for goading her teenage boyfriend into suicide with a series of text messages in 2014 in a case that drew national attention to cyber-bullying.'

Read this Story

Abbott's Alere to resolve securities fraud case for $20 million

Feb 4

Alere Inc, now a unit of Abbott Laboratories Inc, has agreed to pay $20 million to resolve claims it made false and misleading statements to investors in the lead up to the announcement of a deal to sell the diagnostic testing company to Abbott.'

Read this Story

Court fight sheds light on Amazon, Berkshire, JPMorgan health venture

Feb 2

An executive at a new healthcare venture launched by Amazon.com Inc, Berkshire Hathaway Inc and JPMorgan Chase & Co argued this week at a court hearing in Boston that the new venture is not a competitor to his former employer UnitedHealth Group Inc, as he tri…

Read this Story

Insys executive gave doctor lap dance while promoting drug, witness says

Jan 29

An ex-stripper who became a regional sales director at Insys Therapeutics Inc gave a doctor a lap dance at a Chicago club as the drugmaker pushed the doctor to prescribe its addictive fentanyl spray, a former Insys employee testified on Tuesday.

Read this Story

Insys exec gave doctor lap dance while promoting drug, witness says

Jan 29

An ex-stripper who became a regional sales director at Insys Therapeutics Inc gave a doctor a lap dance at a Chicago club as the drugmaker pushed the doctor to prescribe its addictive fentanyl spray, a former Insys employee testified on Tuesday.

Read this Story

'Greed' fuelled Insys founder's opioid bribe scheme - prosecutor

Jan 28

A lawyer for Insys Therapeutics Inc's one-time billionaire founder on Monday rejected claims that her client directed a scheme to bribe doctors to prescribe an addictive fentanyl spray and denied the product was related to the U.S. opioid crisis.

Read this Story

Insys founder ran bribe scheme to push opioid: U.S. prosecutor

Jan 28

Insys Therapeutics Inc's one-time billionaire founder directed a vast scheme to bribe doctors to prescribe an addictive fentanyl spray as opioid addiction was spiraling into a public health crisis, a U.S. prosecutor said on Monday.

Read this Story

Insys founder, former executives face opioid kickback scheme trial

Jan 28

The one-time billionaire founder of Insys Therapeutics Inc and four other former executives and managers of the opioid drugmaker will face trial over charges they conspired to pay doctors bribes to prescribe patients an addictive fentanyl spray to boost sales.

Read this Story

Abbott escapes lawsuit over recalled St. Jude defibrillators

Jan 25

Jan 25 - Abbott Laboratories has escaped a proposed class action lawsuit alleging its subsidiary St. Jude Medical concealed a potentially deadly battery defect in some of its cardiac defibrillators for years before finally recalling them in 2016.'

Read this Story

Former Ariad employee's ex-husband gets prison for insider trading

Jan 17

The ex-husband of a former Ariad Pharmaceuticals Inc employee was sentenced on Wednesday to 18 months in prison after being convicted of misusing information he was given in confidence about the drugmaker's regulatory problems to engage in insider trading.

Read this Story

Ex-employee of proxy solicitor Georgeson convicted of fraud

Jan 15

A former senior managing director of a firm that advises companies on shareholder votes was convicted on Tuesday of participating in a scheme to bribe a proxy adviser's employee with sports and concert tickets to learn how its investor clients were voting.

Read this Story

Family behind Purdue Pharma pushed opioid marketing, Massachusetts says

Jan 15

Members of the wealthy Sackler family behind Purdue Pharma LP personally pushed the company to boost sales of OxyContin and other opioid products even as questions emerged about the extent its painkillers were being abused, Massachusetts' attorney general all…

Read this Story

Teva settles Illinois drug-pricing lawsuit for $135 million

Jan 12

Teva Pharmaceutical Industries Ltd has agreed to pay $135 million to resolve a long-running lawsuit alleging that the generic drugmaker defrauded Illinois' Medicaid program by overstating the wholesale price of its prescription drugs.'

Read this Story